期刊文献+

MicroRNA对缺血性脑卒中自噬调控作用的研究进展 被引量:3

Research progress of microRNA on the regulation of autophagy in ischemic stroke
原文传递
导出
摘要 脑卒中可造成严重的脑部损伤,是人类第二大死亡原因。患者中,缺血性脑卒中更为常见,其发病机制复杂,近年的研究提示细胞自噬参与其中。自噬是一种通过自身降解异常蛋白和受损细胞器维持细胞内环境稳态的分解代谢途径,该过程受基因调控,可抵抗缺血性脑卒中造成的缺血缺氧环境,维持存活状态,但过度的自噬也可直接导致细胞死亡。MicroRNA是一种非编码RNA,可通过与mRNA反向结合,从基因水平上调控多种细胞活动。microRNA可通过对自噬过程的调节而参与缺血性脑卒中多种病理过程的调节。但microRNA在缺血性脑卒中自噬过程中的作用还未完全明晰。本文汇总近年来此领域的最新研究进展,旨在为缺血性脑卒中的基础研究与临床应用奠定理论基础。 Stroke,the second leading cause of death in the world,can lead severe brain impairment.Among patients,ischemic stroke is the most common form with complex pathogenesis,in which autophagy is suggested to be involved.Autophagy is a metabolic pathway that maintains the steady state of the cell environment through its degradation of abnormal proteins and damaged organelles.Via the process,cells can resist the ischemic and hypoxic stress caused by ischemic stroke.MicroRNA is a non-coding RNA that regulates multiple cells activities from the genetic level by inversely binding to mRNA.Recent studies proved that microRNA plays causal roles through regulating autophagy process in ischemic stroke.Herein we summarized the latest studies of this field to illustrate the effects and the underlying mechanism of microRNA on stroke pathogenesis.
作者 杨梦戈 张晓洁 肇玉明 YANG Mengge;ZHANG Xiaojie;ZHAO Yuming(Clinical Medicine,School of Basic Medicine,Capital Medical University,Beijing 100069,China;Department of Pharmacology,School of Basic Medicine,Capital Medical University,Beijing 100069,China;State Key Laboratory for Structural Chemistry of Unstable and Stable Species,Institute of Chemistry,Chinese Academy of Science,Beijing 100190,China)
出处 《生命的化学》 CAS CSCD 2019年第2期338-352,共15页 Chemistry of Life
基金 国家自然科学基金项目(31741035 31570856) 北京市自然科学基金项目(5152005) 2016年北京市教育委员会科技计划一般项目基金(KM201610025003) 山东省自然科学基金项目(ZR2017MH117) 四川省科技厅重点研发项目(2017SZ0201) 首都医科大学本科学生科研训练项目(7NZDS2016)
关键词 MICRORNA 缺血性脑卒中 自噬 microRNA ischemic stroke autophagy
  • 相关文献

参考文献6

二级参考文献64

  • 1朱伦,陈增良.mTOR的结构与功能[J].国际病理科学与临床杂志,2006,26(1):31-34. 被引量:13
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.

共引文献1079

同被引文献41

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部